Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Immucell (ICCC) over the last 10 years, with Q3 2025 value amounting to $207983.0.

  • Immucell's Gains from Investment Securities rose 63637.94% to $207983.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $207983.0, marking a year-over-year increase of 10139.34%. This contributed to the annual value of $149741.0 for FY2024, which is 25642.99% up from last year.
  • According to the latest figures from Q3 2025, Immucell's Gains from Investment Securities is $207983.0, which was up 63637.94% from $38775.0 recorded in Q2 2025.
  • In the past 5 years, Immucell's Gains from Investment Securities registered a high of $1.0 million during Q3 2022, and its lowest value of -$66980.0 during Q3 2023.
  • Its 5-year average for Gains from Investment Securities is $93849.8, with a median of $37717.0 in 2024.
  • As far as peak fluctuations go, Immucell's Gains from Investment Securities tumbled by 12320.18% in 2023, and later skyrocketed by 2959808.92% in 2024.
  • Quarter analysis of 5 years shows Immucell's Gains from Investment Securities stood at $7836.0 in 2021, then skyrocketed by 12984.88% to $1.0 million in 2022, then tumbled by 99.98% to $157.0 in 2023, then surged by 29598.09% to $46626.0 in 2024, then soared by 346.07% to $207983.0 in 2025.
  • Its last three reported values are $207983.0 in Q3 2025, $38775.0 for Q2 2025, and $37998.0 during Q1 2025.